A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.

Weiyong HongFangyuan GuoNan YuSanjun YingBang LouJiangqing WuYing GaoXugang JiHaiying WangAiqin LiGuoping WangQingliang Yang

Published in: Drug design, development and therapy (2021)

These findings suggest that FA-Cur-NPs are a promising approach for improving cancer therapy through active targeting and controllable release.